Asahi Intecc Co., Ltd. (TSE:7747) signed a basic agreement to acquire Pathways Medical Corporation from Cygnus Investment Corporation, Nitin Patil, Phil Houle, Goutam Dutta and Vyanjana Pandya for $23 million on April 12, 2021. Asahi Intecc Co., Ltd. signed a contract to acquire Pathways Medical Corporation from Cygnus Investment Corporation, Nitin Patil, Phil Houle, Goutam Dutta and Vyanjana Pandya on June 7, 2021. Asahi Intecc will consider making Pathways Medical a wholly owned subsidiary. Cygnus Investment Corporation holds 79.5% stake, Nitin Patil holds 12% stake Phil Houle holds 6% stake,Goutam Dutta holds 2% and Vyanjana Pandya holds 0.5% stake in Pathways. Asahi will acquire 1 million shares for $23 million as a milestone in response to the achievement of certain conditions in the future, $7 million which may occur by July 2023. The funds for the acquisition will be applied by the funds procured through the payment and exercise of the 4th share acquisition rights (the share acquisition rights) through a third-party allotment. As on August 20, 2020, Pathways Medical Corporation reported total and net assets of $0.012501 million. The acquisition is expected to be closed by July 1, 2021. Kazuhiro Shimizu, James Abe, Nick Mugge, Martha Doty and Brian Harvel of Alston Bird LLP acted as legal advisor for Asahi Intecc Co., Ltd. Asahi Intecc Co., Ltd. (TSE:7747) completed the acquisition of Pathways Medical Corporation from Cygnus Investment Corporation, Nitin Patil, Phil Houle, Goutam Dutta and Vyanjana Pandya on July 1, 2021.